PP_1170x120_10-25-21

Aurobindo Pharma

Aurobindo gets FDA approval for exemestane tablets USP, 25 mg

Aurobindo gets FDA approval for exemestane tablets USP, 25 mg

EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application exemestane tablets USP, 25 mg. Aurobindo Pharma’s exemestane tablets are an AB-rated generic equivalent to the reference listed drug (RLD), AROMASIN Tablets, manufactured by Pfizer. Exemestane tablets are indicated for adjuvant treatment of

Aurobindo receives FDA approval for vigabatrin tablets

Aurobindo receives FDA approval for vigabatrin tablets

EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application vigabatrin tablets USP, 500mg. Aurobindo Pharma’s vigabatrin tablets are an AB-rated generic equivalent to the reference listed drug (RLD), SABRIL tablets, manufactured by Lundbeck Pharmaceuticals LLC. Vigabatrin tablets are indicated as adjunctive therapy

Aurobindo gets FDA okay for Acyclovir Oral Suspension USP, 200 mg/5 mL

Aurobindo gets FDA okay for Acyclovir Oral Suspension USP, 200 mg/5 mL

EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application acyclovir oral suspension USP, 200 mg/5 mL. Aurobindo Pharma’s acyclovir oral suspension are an AB-rated generic equivalent to the reference listed drug (RLD), ZOVIRAX (acyclovir), of Mylan Pharmaceuticals Inc. Acyclovir oral suspension are

Aurobindo gets FDA approval for Bromfenac Ophthalmic Solution

Aurobindo gets FDA approval for Bromfenac Ophthalmic Solution

EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Bromfenac Ophthalmic Solution 0.09%. Aurobindo Pharma’s Bromfenac Ophthalmic Solution, are an AT-rated generic equivalent to the reference listed drug (RLD), Bromday Ophthalmic Solution, of Bausch & Lomb. Bromfenac Ophthalmic Solution are indicated for

Aurobindo receives FDA approval for clobazam oral suspension, 2.5 mg/mL

Aurobindo receives FDA approval for clobazam oral suspension, 2.5 mg/mL

EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application clobazam oral suspension, 2.5m/mL. Aurobindo Pharma’s clobazam oral suspension, are an AB-rated generic equivalent to the reference listed drug (RLD), ONFI Oral Suspension, of Lundbeck Pharmaceuticals. Clobazam oral suspension are indicated for the

Aurobindo gets FDA nod for digoxin tablets

Aurobindo gets FDA nod for digoxin tablets

EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application digoxin tablets USP, 0.0625 mg, 0.125 mg and 0.25 mg. Aurobindo Pharma’s digoxin tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Lanoxin Tablets USP, of Concordia Pharmaceuticals. Digoxin tablets

Aurobindo receives FDA approval for colchicine tablets

Aurobindo receives FDA approval for colchicine tablets

EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application colchicine tablets USP, 0.6 mg. Aurobindo Pharma’s colchicine tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), COLCRYS Tablets, of Takeda Pharmaceuticals USA, Inc. Colchicine tablets are indicated in adults

Aurobindo launches new website

Aurobindo launches new website

EAST WINDSOR, N.J. — After many months of hard work and dedication from their marketing and web design team, Aurobindo Pharma announces the launch of their new company website. The new site is said to offer a clean and modern design, easy navigation and helpful tools and resources. Through this launch, Aurobindo strives to deliver

Aurobindo receives FDA approval for prednisone tablets

Aurobindo receives FDA approval for prednisone tablets

EAST WINDSOR, N.J. — Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application prednisone tablets USP, 1mg. Aurobindo Pharma’s prednisone tablets USP, 1mg, are an AB-rated generic equivalent to the reference listed drug (RLD), Meticorten Tablets, of Schering Corp Sub Schering Plough Corp. Prednisone tablets are

Aurobindo gets FDA approval for vigabatrin for oral solution

Aurobindo gets FDA approval for vigabatrin for oral solution

EAST WINDSOR, N.J. – Aurobindo Pharma  has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application vigabatrin for oral solution USP, 500mg. Aurobindo Pharma’s vigabatrin for oral solution USP, 500mg, are an AB-rated generic equivalent to the reference listed drug (RLD), Sabril for Oral Solution of Lundbeck Pharmaceuticals. Vigabatrin

Aurobindo receives FDA approval for fenofibrate capsules

Aurobindo receives FDA approval for fenofibrate capsules

EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application fenofibrate capsules USP, 67mg, 134mg, and 200mg. Aurobindo Pharma’s fenofibrate capsules USP, 67mg, 134mg, and 200mg are an AB-rated generic equivalent to the reference listed drug (RLD), Tricor Capsules of AbbVie.

Aurobindo gets FDA approval for memantine hydrochloride ER capsules

Aurobindo gets FDA approval for memantine hydrochloride ER capsules

EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application memantine hydrochloride ER capsules, 7mg, 14mg, 21mg, and 28mg. Aurobindo Pharma’s memantine hydrochloride ER capsules, 7mg, 14mg, 21mg, and 28mg, are an AB-rated generic equivalent to the reference listed drug (RLD), Namenda

Aurobindo gets FDA approval for dorzolamide HCl and timolol maleate ophthalmic solution

Aurobindo gets FDA approval for dorzolamide HCl and timolol maleate ophthalmic solution

EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application dorzolamide HCl and timolol maleate ophthalmic solution, 2% / 0.5%. Aurobindo Pharma’s dorzolamide HCl and timolol maleate ophthalmic solution, are an AT-rated generic equivalent to the reference listed drug (RLD), Cosopt Ophthalmic Solution,

1 2 3 4